https://theconversation.com/pfizer-vaccine-what-an-efficacy-rate-...

  1. 918 Posts.
    https://theconversation.com/pfizer-...-above-90-really-means-149849#comment_2384256

    The last comment by Observer Skeptic

    "This is an extreme misrepresentation of the overall and individual efficacy from Pfizer. It’s a shame that more doctors who can easily do this math aren’t speaking up.

    Luckily though, some doctors have done the math to tell is what the individual efficacy is:

    “based on the 94 cases in a trial that has enrolled about 40,000 subjects: 8 cases in a vaccine group of 20,000 and 86 cases in a placebo group of 20,000. This yields a Covid-19 attack rate of 0.0004 in the vaccine group and 0.0043 in the placebo group. Relative risk (RR) for vaccination = 0.093, which translates into a "vaccine effectiveness” of 90.7% [100(1-0.093)]. This sounds impressive, but the absolute risk reduction for an individual is only about 0.4% (0.0043-0.0004=0.0039). The Number Needed To Vaccinate (NNTV) = 256 (1/0.0039), which means that to prevent just 1 Covid-19 case 256 individuals must get the vaccine; the other 255 individuals derive no benefit, but are subject to vaccine adverse effects"

    So there you have it, the real reason you will still have to social distance after vaccination. The vaccine is highly ineffective. Hardly worth the risk of a rushed vaccine.

    And the risks are high! The precise conditions for ADE, that is Antibody Dependant Enhancement, a condition where the vaccine might cause the body to invite the virus, shown to cause 100% mortality rates in animal trials with Coronavirus vaccines - the precise conditions for this are 1) a vaccine that produces antibodies, and 2) an ineffective vaccine:

    “one risk with any vaccine that winds up ineffective is that they could actually enhance disease.

    The process is called antibody-dependent enhancement (ADE), where a vaccine generates antibodies and binds the virus but does not neutralize it. These antibodies could then enhance viral entry into the cells and increase viral replication, said Sanjay Mishra, PhD, project manager of the COVID-19 and Cancer Consortium in Nashville, Tennessee.”

    “Poor-quality antibodies that bind a virus without neutralizing are one reason why the vaccine candidates often fail,” Mishra told MedPage Today in an email. “Any ineffective vaccine, in theory, could cause ADE.”

    https://www.medpagetoday.com/infectiousdisease/covid19/87933

    These vaccines need a decade of testing before we can truly call them safe and effective. Unfortunately we are testing on the population, with great risk to our health and safety.

    It is no wonder that so many medical personnel are unwilling to be guinea pigs for these vaccines."
 
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.